HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Hiroyasu Yokomise Selected Research
Hiroyasu Yokomise Research Topics
Disease
48
Neoplasms (Cancer)
04/2022 - 04/2002
31
Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
02/2022 - 06/2004
25
Lung Neoplasms (Lung Cancer)
02/2022 - 11/2002
11
Breast Neoplasms (Breast Cancer)
09/2019 - 04/2005
10
Squamous Cell Carcinoma (Epidermoid Carcinoma)
01/2022 - 04/2002
7
Adenocarcinoma of Lung
01/2022 - 08/2017
6
Adenocarcinoma
01/2022 - 04/2002
6
Carcinoma (Carcinomatosis)
01/2021 - 04/2002
6
Carcinogenesis
05/2012 - 04/2002
5
Hemorrhage
02/2017 - 01/2005
4
Pulmonary Emphysema
08/2022 - 12/2003
4
Empyema
09/2021 - 05/2009
4
Fistula
09/2021 - 11/2009
4
Emphysema
08/2014 - 10/2002
4
Neoplasm Metastasis (Metastasis)
12/2007 - 01/2004
3
Pathologic Processes
05/2012 - 01/2008
2
Pulmonary Hypertension
01/2021 - 11/2020
2
Lymphatic Metastasis
10/2018 - 08/2017
2
Atrial Fibrillation
02/2017 - 04/2015
2
Malignant Mesothelioma
12/2015 - 03/2004
2
Small Cell Lung Carcinoma (Small Cell Lung Cancer)
03/2011 - 11/2003
2
Tracheomalacia
02/2004 - 01/2003
1
Lung Diseases (Lung Disease)
04/2022
1
Right Ventricular Hypertrophy
01/2021
1
Hypertrophy
01/2021
1
Vascular Remodeling
11/2020
1
Fever (Fevers)
10/2020
1
Febrile Neutropenia
12/2018
1
Infections
12/2018
1
Lipoma (Lipomata)
11/2018
1
Disease Progression
10/2018
1
Hypertension (High Blood Pressure)
01/2018
1
Proteinuria
01/2018
Drug/Important Bio-Agent (IBA)
10
Biomarkers (Surrogate Marker)
IBA
01/2022 - 04/2006
8
xylometazoline (stas)
IBA
02/2022 - 08/2017
6
Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)
IBA
01/2018 - 06/2004
5
Pancreatic Elastase (Elastase)
IBA
08/2022 - 12/2003
5
Gelatin
IBA
08/2022 - 01/2003
5
Carboplatin (JM8)
FDA Link
Generic
10/2018 - 04/2006
5
Survivin
IBA
05/2012 - 11/2005
4
Indocyanine Green (Cardio-Green)
FDA Link
Generic
01/2021 - 12/2007
4
Tubulin
IBA
01/2018 - 05/2010
4
taxane
IBA
01/2018 - 05/2007
3
Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)
IBA
12/2015 - 11/2009
3
Thymidylate Synthase
IBA
12/2013 - 04/2006
3
Glycoproteins (Glycoprotein)
IBA
05/2012 - 01/2008
3
Antigens
IBA
04/2007 - 12/2004
3
Biological Products
IBA
02/2007 - 05/2005
2
Steroids
IBA
04/2022 - 05/2009
2
G-Protein-Coupled Receptors (Receptors, G Protein Coupled)
IBA
02/2020 - 07/2014
2
titanium silicide (TS-1)
IBA
09/2019 - 01/2017
2
Paclitaxel (Taxol)
FDA Link
Generic
10/2018 - 01/2018
2
Bevacizumab (Avastin)
FDA Link
01/2018 - 12/2015
2
Platinum
IBA
01/2017 - 03/2011
2
Cytotoxins (Cytolysins)
IBA
06/2016 - 05/2014
2
Gemcitabine
FDA Link
11/2015 - 04/2006
2
Ribonucleotide Reductases (Ribonucleotide Reductase)
IBA
11/2015 - 04/2006
2
Hormones (Hormone)
IBA
11/2014 - 03/2013
2
Messenger RNA (mRNA)
IBA
07/2014 - 11/2003
2
Carcinoembryonic Antigen
IBA
03/2012 - 06/2011
2
Deoxyglucose (2 Deoxy D glucose)
IBA
07/2011 - 12/2006
2
Elements
IBA
04/2007 - 11/2002
2
ErbB Receptors (EGF Receptor)
IBA
06/2006 - 04/2006
2
Proteins (Proteins, Gene)
FDA Link
05/2006 - 11/2003
2
DNA (Deoxyribonucleic Acid)
IBA
05/2006 - 02/2004
2
Bone Morphogenetic Proteins (Bone Morphogenetic Protein)
IBA
02/2004 - 01/2003
1
Prednisolone (Predate)
FDA Link
Generic
04/2022
1
Tin
IBA
01/2022
1
Pharmaceutical Preparations
IBA
11/2021
1
Monocrotaline
IBA
01/2021
1
monocrotaline pyrrole
IBA
01/2021
1
Therapeutic Uses
IBA
01/2021
1
Catenins
IBA
01/2021
1
src-Family Kinases
IBA
11/2020
1
Proto-Oncogene Proteins c-fyn
IBA
11/2020
1
Eicosapentaenoic Acid
IBA
11/2020
1
Anaplastic Lymphoma Kinase
IBA
01/2019
1
pegfilgrastim (Neulasta)
FDA Link
12/2018
1
Anthracyclines
IBA
01/2018
1
Tissue Inhibitor of Metalloproteinase-1
IBA
01/2018
1
Type II DNA Topoisomerases (Topoisomerase II)
IBA
01/2018
Therapy/Procedure
21
Therapeutics
04/2022 - 11/2003
14
Drug Therapy (Chemotherapy)
12/2018 - 04/2002
11
Chemoradiotherapy
10/2018 - 05/2007
8
Thoracotomy
11/2018 - 10/2002
5
Segmental Mastectomy (Lumpectomy)
02/2022 - 01/2006
4
Pneumonectomy (Lung Volume Reduction)
02/2022 - 10/2002
4
Immunotherapy
11/2021 - 12/2004
4
Radiotherapy
11/2021 - 01/2004
3
Operative Surgical Procedures
09/2021 - 10/2012
2
Neoadjuvant Therapy
08/2020 - 09/2016
2
Traction
01/2016 - 06/2011
2
Microspheres (Microsphere)
08/2014 - 11/2008
2
Sutures (Suture)
04/2012 - 12/2011
2
Thyroidectomy
07/2005 - 03/2004
1
Aftercare (After-Treatment)
04/2022
1
Thoracostomy
09/2021
1
Curettage
10/2020
1
Secondary Prevention
12/2018
1
Consolidation Chemotherapy
10/2018